• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
NPCE

NPCE

NeuroPace, Inc.

NASDAQHealthcareMedical - DevicesUS

USD15.88

-0.41 (-2.52%)

Rating:D+

Company Profile

CEO

Joel D. Becker

IPO Date

2021-04-22

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

Market Metrics

Open

$16.21

Prev. Close

$16.29

Day Low

$15.69

Day High

$16.58

52W Low

$7.56

52W High

$19.60

Market Cap

$0.54B

Volume

0.18M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

5

Avg Positive

7.2%

Avg Negative

2.6%

Avg Neutral

90.0%

News Feed

NeuroPace's (NPCE) CEO Mike Favet on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·6/3/2021·↓ negative

NeuroPace To Report First Quarter 2021 Financial Results on June 3, 2021

GlobeNewsWire·5/20/2021·↓ negative

NeuroPace, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

GlobeNewsWire
·4/26/2021
·↑ positive

NeuroPace: Plenty Of Space To Grow

Seeking Alpha·4/25/2021·↑ positive

NeuroPace, Inc. Announces Pricing of Initial Public Offering

GlobeNewsWire·4/21/2021·↑ positive